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Prescribing an equilibrated intermittent hemodialysis dose in
intensive care unit acute renal failure.
Background. Prospective, formal, blood-side, urea kinetic
modeling (UKM) has yet to be applied in intermittent
hemodialysis for acute renal failure (ARF). Methods for pre-
scribing a target, equilibrated Kt/V (eKt/V) are described for
this setting.
Methods. Serial sessions (N = 108) were studied in 28 inten-
sive care unit ARF patients. eKt/V was derived using delayed
posthemodialyis urea samples and formal, double-pool UKM
(eKt/Vref), and by applying the Daugirdas-Schneditz venous
rate equation to pre- and posthemodialysis samples (eKt/Vrate).
Individual components of prescribed and delivered dose were
compared. Prescribed eKt/V values were determined using in
vivo dialyzer clearance estimates and anthropometric (Watson
and adjusted Chertow) and modeled urea volumes.
Results. eKt/Vref (mean ± SD = 0.91 ± 0.26) was well-
approximated by eKt/Vrate (0.92 ± 0.25), R = 0.92. Modeled
V exceeded Watson V by 25% ± 29% (P < 0.001) and Ad-
justed Chertow V by 18% ± 28% (P < 0.001), although the
degree of overestimation diminished over time. This difference
was influenced by access recirculation (AR) and use of saline
flushes. The median % difference between Vdprate and Watson
V was reduced to 1% after adjusting for AR for the 22 sessions
with ≤1 saline flush. The median coefficients of variation for
serial determinations of Adjusted Chertow V, modeled V, urea
generation rate, and eKt/Vref were 2.7%, 12.2%, 30.1%, and
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16.4%, respectively. Because of comparatively higher modeled
urea Vs, delivered eKt/Vref was lower than prescribed eKt/V,
based on Watson V or Adjusted Chertow V, by 0.13 and 0.08
Kt/V units. The median absolute errors of prescribed eKt/V vs.
delivered therapy (eKt/Vref) were not large and were similar in
prescriptions based on the Adjusted Chertow V (0.127) vs. those
based on various double-pool modeled urea volumes (∼0.127).
Conclusion. Equilibrated Kt/V can be derived using formal,
double-pool UKM in intensive care unit ARF patients, with the
venous rate equation providing a practical alternative. A target
eKt/V can be prescribed to within a median absolute error of less
than 0.14 Kt/V units using practical prescription algorithms. The
causes of the increased apparent volume of urea distribution
appear to be multifactorial and deserve further investigation.
Blood-side, urea-based dosing of intermittent hemo-
dialysis (IHD) is well established in end-stage renal
disease (ESRD). Associations between outcome and
measures of dialysis dose, derived through formal urea
kinetic modeling (UKM) [1–7], have led to the develop-
ment of dosing standards for the ESRD patient [8].
The use of such dosing techniques becomes problem-
atic when applied to the critically ill patient with acute
renal failure (ARF). Confounding the steady-state as-
sumptions of formal UKM [9, 10] is the potential for
variations in both the urea generation rate (G) [11–13]
and urea distribution volume (V) [14]. In addition, re-
gional blood flow maldistribution [15–18] may lead to
varying postdialysis urea rebound, suggesting that mea-
surement of an equilibrated dialysis dose may be more
appropriate in this setting. Practical issues, such as varia-
tions in the dialysis schedule and interruptions to therapy,
may be more common in ARF dialysis and may compli-
cate attempts to model urea removal by blood-side UKM.
Such patients are usually dialyzed with venous catheters,
which are prone to access recirculation (AR). AR lowers
the intradialytic blood urea nitrogen (BUN) presented
to the dialyzer, resulting in a reduction of urea removal.
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Similarly, many ARF patients are dialyzed using a
heparin-free protocol with the use of frequent saline
flushes to maintain circuit patency. The dilutional effect
of saline flushes and intradialytic infusions on the BUN
concentration during dialysis can also lower the amount
of urea removed.
The number of studies addressing IHD dosing in ARF
is limited [19–22]. None have prospectively examined for-
mal single- or double-pool UKM and none have defined
the impact of changing clinical and dialytic factors on dose
prescription and delivery.
The objective of this study was to define and evaluate
a method of prescribing a target equilibrated Kt/V for in-
tensive care unit ARF patients that could be used in prac-
tice. We approached this objective in three stages. In the
first stage, we applied the formal, double-pool variable
volume model [23] to determine a reference estimate of
equilibrated Kt/V (eKt/V), based on BUN measurements
obtained at the beginning and end of dialysis and at 30
or 60 minutes after dialysis. The reference estimate may
be difficult to obtain in routine practice since it requires
blood sampling at least 30 minutes after dialysis. Thus,
in the second stage of our analysis, we evaluated the va-
lidity of the venous version of the Daugirdas-Schneditz
rate equation [18] (which requires only the standard pre-
and postdialysis BUN measurements) by comparing the
rate equation estimate of eKt/V to the reference eKt/V
value. In the third stage, we defined a prescription algo-
rithm, based on the venous rate equation, and examined
its performance in achieving a target eKt/V. We evaluated
two anthropometric estimates of total body water in the
development of the prescription algorithm: the Watson
V (derived from dilution studies in nonuremic subjects)
[24] and the Chertow V (determined from a large ESRD
cohort) [25].
METHODS
Data collection
Serial dialyses (maximum of 12/patient) were studied,
from dialysis initiation, in intensive care unit patients with
ARF (defined as a rise in serum creatinine of ≥0.5 mg/dL
from a baseline≤1.9 mg/dL, or a rise of≥1.0 mg/dL from a
baseline of > 1.9 and ≤4.9 mg/dL). Patient eligibility con-
ditions also included age ≥18 years old, dialysis initiation
in the intensive care unit, and informed consent for study.
IHD utilized F50 dialyzers (Fresenius, Lexington, MA,
USA), single-pass, proportioning dialysis machines (Al-
thin 1000) (Althin CD Medical, Inc., Miami, FL, USA),
bicarbonate dialysate, and temporary or tunneled ven-
ovenous access, according to standard unit protocol. The
dialysis prescription was that of the attending nephrolo-
gist, who included one of the authors (E.P.P.). In a major-
ity of sessions, a heparin-free dialysis method was used,
with 200 mL saline flushes infused through the extracor-
poreal blood circuit every 30 minutes. Additional flushes
were administered to prevent circuit clotting during both
heparin-anticoagulated and heparin-free sessions, at the
discretion of the dialysis nurse.
The following were recorded for each dialysis: pre-
and posthemodialysis weights, the dialysis prescription
and subsequent changes during treatment, interruptions
(which were timed), and complications. BUN was mea-
sured pre- and posthemodialysis and at post + 30 minutes
and + 60 minutes. Immediate posthemodialysis blood
sampling used a modification of the stop-pump method
[8]. Briefly, after ultrafiltration was stopped and dialysate
flow put into bypass (defined as the end of dialysis), in
quick succession, blood flow (Qb) was dropped to 50 mL/
min and the venous return was clamped while over-riding
the venous pressure alarm (so maintaining the Qb). Af-
ter 10 seconds, Qb was stopped, the arterial blood line
was clamped distal to its sampling port, and nonrecir-
culated, posthemodialysis bloods were drawn from this
port. Thereafter, patient disconnection proceeded as per
unit protocol. In an intensively monitored subset of dial-
ysis sessions (maximum of seven/patient), AR was deter-
mined, by the Transonic method [26] (HD-01 monitor)
(Transonic Systems, Ithaca, NY, USA), as the mean of
two readings taken 30 minutes after starting hemodialy-
sis, with these readings repeated if the blood lines were
later reversed. In 49 of these intensive sessions, simul-
taneous measurements of the transonic Qb and in vivo
cross-dialyzer extraction ratios were obtained after the
start, at the midpoint, and before the end of hemodialy-
sis, and the associated in vivo KoA values computed (see
Appendix, Part 4). The in vivo urea KoA for the F50 dia-
lyzer, used in the UKM below, was taken to be the median
(457 mL/min), over the 49 sessions, of the average of the
three in vivo KoAs measured at the three time points dur-
ing these sessions [in comparison, the in vitro KoA of the
F50 is reported to be 577 mL/min (manufacturer’s data)].
Residual renal function (Kr) was estimated between
sessions with timed urine collections if daily urine output
was >200 mL. This was performed at least once weekly
and during each interdialysis period between intensively
monitored sessions. Interdialysis blood samples for BUN
were recorded and accurately timed to allow for better
monitoring of changes in G.
Two anthropometric estimates of V were calculated,
the Watson V [24] and an adjustment of the Chertow V
[25] that takes into account the change in weight during
dialysis (see Appendix, Part 3).
In total, 130 sessions were followed. Twenty-two of
these sessions were excluded for one or more of the fol-
lowing reasons: periods of isolated ultrafiltration, missing
BUNs (the pre- or immediate posthemodialysis BUNs,
or both of the delayed posthemodialysis BUNs), session
length <2 hours, or other missing data preventing calcu-
lation of reference-standard eKt/V (see below).
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UKM and computation of eKt/V from the rate equation
For each modeled dialysis, an initial estimate of the
prehemodialysis G was calculated from Kr, the Watson
anthropometric V [24] plus net ultrafiltration, and the
BUN over an immediate prehemodialysis period of at
least 4 hours (see Appendix, Part 1). Posthemodialysis
G was similarly calculated using Kr, Watson V, and the
BUN over a posthemodialysis period of at least 4 hours
starting from post + 60 minutes. The pre- and postdialysis
estimates of G were averaged to obtain a mean G for the
session. Calculation of G from the observed changes in
BUN before and after dialysis avoids the need to assume
a constant G over time, an assumption that is likely to be
frequently violated in the intensive care unit. This value of
G, the dialyzer clearance, Kd (computed from the median
in vivo KoA of 457 mL/min, the reported Qb at 30 min-
utes, and the reported Qd), Kr, the treatment time, Td,
the pre- and postdialysis BUNs, and the pre- and postdial-
ysis weights, were used to compute the single pool urea
volume, Vsp, based on the single-pool, variable-volume
model (equation 4.29 of Depner [9]). The resulting Vsp
was adjusted to correct for the effects of intercompart-
ment disequilibrium by the rate correction of Daugirdas
et al [27] to obtain an estimated double-pool V, Vdprate.
Since errors in kinetically determined V may be frequent
in the ARF setting, we next obtained the median Vdprate
over all the modeled dialyses for each patient to min-
imize the impact of individual sessions with erroneous
kinetic Vs. To account for variations in total body water
during the patient’s stay in the intensive care unit, weight-
adjusted values of Vdprate [Vdp(wtadj)] were then calcu-
lated for each dialysis based on the median Vdprate and
weight changes between dialyses (see Appendix, Part 2).
The sequence of calculations described in the above para-
graph was repeated twice, now using Vdp(wtadj) rather
than the Watson V to estimate G at each iteration. Af-
ter the final iteration, the following kinetic parameters
were computed: G = mean of the final pre and posthe-
modialysis estimates of G; Vsp = result of applying the
single-pool variable-volume model to G, Kd, Kr, Td, and
the pre- and postdialysis weights (equation 4.29 of Dep-
ner [9]); spKt/V = Kd × Td/Vsp; eKt/Vrate = spKt/V –
0.47 K/V + 0.02; Vdprate = adjustment of Vsp based on
[27]; and Vdp(wtadj) = weight-adjusted median Vdprate
(see above and Appendix, Part 2).
The expression for eKt/Vrate is the Daugirdas-
Schneditz rate equation for eKt/V when venous accesses
are used [18]. In this expression, K/V is calculated as
(spKt/V)/Td expressed in h−1.
Computation of eKt/V from actual postdialysis rebound
In order to estimate the equilibrated BUN (Ceq) based
on the observed postdialysis rebound at 60 minutes,
the Runge-Kutta algorithm was used to obtain curve-
fit solutions to the double-pool, variable-volume (dpvv)
model [23] based on the prehemodialysis, posthemodial-
ysis, and post + 60 minutes hemodialysis BUNs. Kr, Kd,
and the final value of G, as described above, were also
taken as input parameters for the curve fit; output pa-
rameters included the double-pool V (Vdpref), the inter-
compartmental (between intra- and extracellular spaces)
mass-transfer coefficient of urea (Kc), the fully equili-
brated postdialysis BUN (Ceq60), and eKt/V (eKt/V60).
A similar procedure was used to obtain curve-fit so-
lutions for the prehemodialysis, posthemodialysis, and
post + 30 minutes hemodialysis BUNs (to give Ceq30
and eKt/V30), and when all four BUN measurements
were available for the prehemodialyis, posthemodialysis,
post + 30 minutes hemodialysis, and post + 60 minutes
hemodialysis BUNs (to give Ceq30,60 and eKt/V30,60). The
notation Ceqref and eKt/Vref is used to refer to Ceq60 and
eKt/V60 for the 104 dialyses where the post + 60 minutes
hemodialysis BUN was obtained, and Ceq30 and eKt/V30
for the remaining four dialyses where the post + 30 min-
utes but not the post + 60 minutes hemodialysis BUN
was available.
The magnitude of the postdialysis rebound associated
with the curve-fit solution was expressed as Kt/V =
spKt/V − eKt/Vref. Percentage rebound was also calcu-
lated, using the actual posthemodialysis BUNs, to yield
%Rb30 (using the actual post + 30 minutes BUN) and
%Rb60 (using the actual post + 60 minutes BUN). These
were reported before and after correction of the actual
BUNs for mean G.
Assessment of the Daugirdas-Schneditz venous
rate equation
The accuracy of the Daugirdas-Schneditz venous rate
equation was evaluated by comparing eKt/Vrate to
eKt/Vref.
Comparison of dialysis prescription with delivered dose
Deviations between the prescribed eKt/V (rx eKt/V)
and actual eKt/V may occur either because of deviations
in the components of Kt (e.g., prescribed vs. actual Qb,
prescribed vs. actual treatment time), true variations in
V over time, changes in intercompartmental blood flow
or mass transfer coefficient, or fluctuations in the calcu-
lated V due to errors associated with kinetic modeling
(e.g., access recirculation, problems with blood sampling,
laboratory measurement error). In the case of rx eKt/V,
with V derived anthropometrically (rx eKt/V(Watson) or
rx eKt/V(AdjustedChertow)), prescribed eKt/V may also de-
viate from actual eKt/V due to deviations between the
true V and the estimate of V by the Watson or Adjusted
Chertow formulas.
We evaluated these different potential sources of er-
ror. Comparisons between Watson or Adjusted Chertow
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V and modeled V, and between the components of pre-
scribed and actual Kt, were conducted in the full data set.
The within-patient, intersession variability of relevant pa-
rameters for prescribed or delivered eKt/V was summa-
rized by the coefficient of variation (CV) and by the mean
and median of the absolute deviations between consecu-
tive pairs of measurements (mean and median ||). These
assessments of variability were restricted to 22 of the 28
patients who had at least two modeled dialyses (total of
102 dialysis sessions). Vsp, Vdprate, and dependent kinetic
parameters were calculated without a weight-adjustment
in this analysis.
Effect of intrasession variability in blood or dialysate
flow and of access recirculation
We constructed a restricted data set in which sessions
were excluded if the pump-set Qb varied by ≥100 mL/min
for >15 minutes, the Qd was interrupted for >15 min-
utes, the session was interrupted, or the blood lines were
reversed on the vascular access after starting hemodial-
ysis. Relevant parameters were compared between this
restricted data set and the remaining dialysis sessions con-
taining at least one of the noted difficulties.
For analyses of the full data set, the dialyzer clearance
was not adjusted for AR, which was evaluated for only 63
of the 108 modeled dialyses. This reflects the most com-
mon situation in ARF where AR is usually not measured.
However, in a restricted data set consisting of the 63 mod-
eled dialyses in which AR was measured, we evaluated its
effect on the calculation of modeled Vdprate by compar-
ing the standard calculation of Vdprate, described above,
to an alternative estimate of Vdp, obtained when the dia-
lyzer clearance, Kd, is adjusted downward to account for
AR, as described in Depner [9].
Development of prescription method for a target eKt/V
The calculation of prescribed Kt/V depends on the pre-
scription parameters that determine Kt (e.g., prescribed
Qb, Qd, in vivo KoA, and treatment time) and on the
estimated urea volume, V. We considered five different
definitions of prescribed Kt/V based on the following
five estimates of V: (1) Watson V based on the pa-
tient’s current body weight, (2) Adjusted Chertow V (see
Appendix, Part 3) based on the patient’s current body
weight, (3) Vdprate from the most recent modeled dialy-
sis (Vsp from that session with rate correction [27]), (4)
the median Vdprate of all preceding dialyses for the same
patient, and (5) median Vdprate over preceding sessions
plus the difference between the current posthemodial-
ysis weight and the median posthemodialysis weight of
the preceding sessions. While the actual posthemodial-
ysis weight cannot be directly measured until after the
dialysis is completed, it can be estimated from the prehe-
modialysis weight and the prescribed net ultrafiltration;
hence the posthemodialysis weight may be plausibly in-
cluded in definition (5) for the prescribed Kt/V.
For formal calculation of the prescribed equilibrated
Kt/V (denoted rx eKt/V), we used the equation:
rx eKt/V = (rxKd × rxTd)/(V × vratio)
− 0.47 × [K/(V × vratio)] + 0.02
where rxKd is the prescribed dialyzer clearance from
prescribed Qb and Qd, rxTd denotes prescribed treat-
ment time, vratio is an estimate of the ratio of single-
pool to double-pool V (based on [27], see also Appendix,
Part 5), and V is one of the five estimates of V de-
fined in (1) to (5) above [yielding rx eKt/V(Watson), rx eKt/
V(AdjustedChertow), rx eKt/V(lastVdp), rx eKt/V(medVdp) and
rx eKt/V(wt.adj-medVdp), respectively]. The equation shown
above is motivated by noting that if V is an estimate of
the true double-pool V, then V × vratio estimates single-
pool V, (rxKd × rxTd)/(V × vratio) gives the prescribed
single-pool Kt/V, and the right hand side of the equation
gives the prescribed eKt/V by the venous rate equation
[18]. K/V is expressed in h−1. These were compared to
eKt/Vref for those sessions that remained after the first
session for each patient was excluded.
Statistical analysis
The agreement between spKt/V and eKt/Vref, between
different estimates of eKt/V (e.g., eKt/Vref vs. eKt/Vrate)
and of V, and between estimates of prescribed vs. de-
livered eKt/V was evaluated using the Pearson corre-
lation, Rp, to assess linear association, the median dif-
ference (Med) to evaluate bias, and the concordance
correlation coefficient (Rc), median absolute difference
(Med||), and median % absolute difference (Med|%|)
to evaluate overall agreement. Wilcoxon signed-rank
tests were used to compare %Rb30 and %Rb60 vs.
%Rbref.
Mixed effects models with a compound symmetry as-
sumption to account for multiple sessions in the same pa-
tients were used to compare components of prescribed
and delivered dose for those sessions with technical dif-
ficulties (see above) to the remaining sessions without
technical difficulties. A mixed effects analysis was also
performed in the subset of patients with AR measure-
ments to relate the percent difference between the AR-
corrected modeled V and Watson V to the number of
saline flushes used during the dialysis based on a linear
regression model: mean % difference = A + B × (# of
flushes).
RESULTS
A total of 130 sessions were studied in 28 patients
(18 male) who were dialyzed predominantly on alternate
day treatment schedules (mean ± SD interdialytic time
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Table 1. Summary of treatment parameters
Individual dialyses Patient mean values
Parameter Number Mean ± SD Minimum Maximum Number Mean ± SD Minimum Maximum
Reported Qba mL/min 107 364 ± 30 270 450 28 358 ± 25 270 402
Prescribed Qb mL/min 108 370 ± 30 300 450 28 366 ± 24 300 400
Qd mL/min 108 541 ± 102 500 800 28 557 ± 99 500 800
Delivered treatment time minutes 108 230 ± 29 179 281 28 229 ± 24 181 272
Pre-blood urea nitrogen mg/dL 108 103.6 ± 37.6 29.0 220.4 28 106.8 ± 34.4 45.3 196.8
Post-blood urea nitrogen mg/dL 108 45.4 ± 20.0 11.8 97.9 28 47.1 ± 18.4 16.3 82.3
Post + 60 minutes blood urea nitrogen mg/dL 104 51.1 ± 20.9 12.9 112.9 28 52.6 ± 19.3 19.4 90.9
Kr urea nitrogen mL/min 108 2.0 ± 3.1 0 16.9 28 2.5 ± 3.9 0 16.9
Kr creatinine mL/min 108 4.1 ± 5.7 0 33.0 28 5.3 ± 7.6 0 33.0
Predialysis weight kg 108 85.3 ± 19 44.3 129.7 28 85.4 ± 18.6 55.2 126.3
Postdialysis weight kg 108 82.8 ± 18.7 42.2 127.9 28 83.0 ± 18.5 52.0 123.2
Achieved UF mL 106 2489 ± 1455 −1500 6000 28 2366 ± 1117 −675 4157
Watson V L 108 41.1 ± 8.3 26.3 59.2 28 40.7 ± 8.1 27.1 57.6
Adjusted Chertowb V L 108 43.7 ± 9.7 26.4 67.6 28 43.4 ± 9.7 26.4 64.4
a30 minutes into dialysis; bAdjusted Chertow V defined by subtracting net weight loss during dialysis from the standard predialysis Chertow V.
Table 2. Derived urea kinetic modeling (UKM) parameters
Individual dialyses Patient Mean Values
Parameter Number Mean ± SD Minimum Maximum Number Mean ± SD Minimum Maximum
Prescribed Kt L 107 47.5 ± 6.6 34.4 58.4 28 46.9 ± 5.4 36.6 57.1
spKt/V 108 1.02 ± 0.27 0.48 1.64 28 1.00 ± 0.23 0.58 1.52
eKt/Vref 108 0.91 ± 0.26 0.48 1.58 28 0.90 ± 0.21 0.56 1.43
 Kt/V 108 0.11 ± 0.10 −0.05 0.49 28 0.10 ± 0.06 −0.01 0.24
Vsp L 108 49.4 ± 12.4 26.1 83.2 28 49.7 ± 10.9 31.6 72.7
Vdprate L 108 50.9 ± 13.5 25.1 88.3 28 51.1 ± 12.1 30.6 75.3
Vdpref L 108 51.0 ± 13.8 25.8 86.6 28 51.1 ± 12.0 30.8 76.7
%, Vdprate vs. Watson V 108 24.8 ± 28.9 −20.7 148.3 28 26.4 ± 21.4 −10.3 66.6
%, Vdprate vs. Adjusted Chertow V 108 18.0 ± 28.1 −24.6 151.2 28 19.5 ± 22.2 −13.8 69.5
eKt/Vrate 108 0.92 ± 0.25 0.43 1.47 28 0.90 ± 0.20 0.52 1.36
Urea G mg/min 108 11.3 ± 7.5 0.55 35.4 28 10.4 ± 6.4 1.4 22.9
%Rbref 108 11.4 ± 11.2 −3.4 55.2 28 10.5 ± 6.7 0.6 25.4
interval = 46.6 ± 17.9 hours). A total of 108 of these
sessions were retained in the main data set, including at
least one session in each of the 28 patients, with a mean
of 3.9 sessions per patient (range 1 to 10 sessions). The
22 excluded sessions included five sessions with isolated
ultrafiltration or premature termination of dialysis prior
to 2 hours, 15 sessions with missing BUNs, and two ad-
ditional sessions with other missing data that prevented
calculation of eKt/Vref. Intensive monitoring was carried
out in 66 dialysis sessions, with at least one AR measure-
ment in 63 sessions, and all three cross-dialyzer clearance
measurements obtained in 49 dialyses.
The mean age of the 28 patients was 63.8 ± 10.4 years
(43 to 80 years), with the following racial mix: white (N =
23), African American (N = 2), and Middle Eastern (N =
3). The primary diagnoses were cardiothoracic surgical
(N = 11), trauma (N = 1), other surgical (N = 4), car-
diac medical (N= 6), and other medical (N = 6). Re-
nal diagnoses were acute tubular necrosis (N = 20),
acute on chronic renal failure (N = 5), ARF, unspeci-
fied (N = 3). The extracorporeal circuit was maintained
with saline flushes in 60 sessions, systemic anticoagula-
tion and/or prefilter, unfractionated heparin in 56 sessions
(nine sessions with combined flush and anticoagulation
strategy; one session with no flush and no data on systemic
anticoagulation).
Summary of UKM parameters
Basic treatment parameters are summarized in Table 1
(solute levels are shown with plasma water correction
[9]), and derived UKM parameters in Table 2. Eight of
the 28 patients were anuric; the median residual renal
urea clearance was 1.9 mL/min among the remaining
20 patients. After averaging over the dialysis sessions for
each patient, the mean urea generation rate G was 10.4 ±
6.4 mg/min. The mean treatment time and Qb (reported
30 minutes into dialysis) were 229 min and 358 mL/
min, respectively. On a per-session basis, the Pearson
correlation between Vdprate and Vdpref was +0.960, and
the median percent absolute deviation between the two
volume estimates was 2.1%. After averaging over each
patient’s modeling sessions, the Pearson correlation be-
tween the two volume estimates for the 28 patients was
+0.986, and the median percent absolute deviation was
1.4%. On a patient basis, the mean values of Vsp, Vdprate,
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Fig. 1. Comparison of single-pool Kt/V versus curve-fit equilibrated
Kt/V.
and Vdpref were 49.7 ± 10.9 L, 51.1 ± 12.1 L, and
51.1 ± 12.0 L, respectively. The two estimates of Vdp av-
eraged about 25% higher than the mean Watson V of 40.7
± 8.1 L, and about 18% higher than the mean Adjusted
Chertow V of 43.4 ± 9.7 L. For 22 patients with more
than one modeling session, body weight and estimates of
V tended to decline for the later modeling sessions. In
these patients, the postdialysis weight declined by 4.2 ±
7.4 kg, the Adjusted Chertow V declined by 1.2 ± 2.7 L,
and Vdprate declined by 3.2 ± 11.9 L between the first
and last kinetic modeling sessions. The median value of
Kc over the 108 modeled dialyses was 940 mL/min, with
25th and 75th percentiles of 560 and 1867 mL/min, re-
spectively. For 22 patients with at least two sessions, the
median percent deviation of the individual session Kc
from the patients’ median Kc values was 36.6%, indicat-
ing a substantial longitudinal variability in the estimates
of Kc between sessions.
Assessment of postdialysis rebound and the
Daugirdas-Schneditz venous rate equation
As anticipated, the spKt/V overestimated delivered
dose in comparison to the reference standard eKt/Vref
(Table 2) (Fig. 1). This overestimation reflected a mean
postdialysis urea rebound of 11.4% ± 11.2% between
the immediate posthemodialysis BUN and fully equili-
brated posthemodialysis BUN (Ceqref), estimated from
the curve fit under the dpvv model. As shown in Figure 2,
the estimated complete rebound (%Rbref) based on the
curve fit was similar to the observed rebound at 60 min-
utes posthemodialysis (%Rb60) after correction for urea
generation. The %Rb60 was significantly greater than re-
bound at 30 minutes posthemodialysis (%Rb30), but the
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Fig. 2. Observed postdialysis rebound at 30 and 60 minutes, after cor-
rection for G, in comparison to rebound from the dpvv curve-fit solution.
difference in rebound between the 30 and 60 minutes
posthemodialysis samples was small in most patients. We
note that a failure to correct the observed rebound for
G gave the false impression that rebound was actually
complete by 30 minutes when compared to the curve-fit
reference standard, %Rbref; without adjustment for G,
the percent rebound at 30 minutes (mean of 11.5%) did
not differ significantly from Rbref (P = 0.45) and the per-
cent rebound at 60 minutes (mean of 14.6%) appeared to
exceed%Rbref (<0.001).
As shown in Table 3, the curve-fit estimate of equi-
librated Kt/V, based on both the 30 and 60 minutes
post-BUNs (eKt/V30,60), agreed closely with the curve-fit
estimate obtained using only the 60 minutes post-BUN
(eKt/V60) (Rc = 0.99, Med|| = 0.017) and with the
estimated eKt/V, obtained using only the 30 minutes
post-BUN (eKt/V30) (Rc = 0.97, Med|| = 0.018). The
values of eKt/V60 and eKt/V30 also agreed closely with
each other (Rc = 0.96, Med|| = 0.047).
As shown in the bottom row of Table 3 and Figure 3,
there was generally close agreement between eKt/Vref
and eKt/Vrate (Rc = 0.92, Med|| = 0.049) for the 108
individual dialysis sessions. A similar level of agreement
was observed when results were averaged for the 28 pa-
tients (Rc = 0.94, Med|| = 0.040).
Comparison of dialysis prescription with delivered dose
Components of prescription and delivery were com-
pared in 107 sessions in the global data set (one session
excluded with missing data). There were trends toward a
lower achieved Qb in comparison to its prescription, with
a difference of 5.2 ± 24.4 mL/min (P= 0.06).
Within-patient, session-by-session variability of se-
lected parameters are shown in Table 4 for the 22 patients
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Table 3. Comparison of estimates of eKt/V
eKt/V Comparison Number Rp Rc Med Med|| Med|%|
eKt/V(30) vs. eKt/V(30,60) 86 0.967 0.966 +0.003 0.018 1.9%
eKt/V(60) vs. eKt/V(30,60) 86 0.991 0.991 −0.002 0.017 1.1%
eKt/V(30) vs. eKt/V(60) 86 0.964 0.964 +0.008 0.047 3.4%
eKt/Vrate vs. eKt/Vref 108 0.923 0.922 −0.017 0.049 5.4%
Note: eKt/Vref = eKt/V(60) for 104 of the 108 kinetic modeling sessions with 60 minutes postdialysis BUNs, and eKt/Vref = eKt/V(30) for the remaining four modeling
sessions where the 60 minutes postdialysis BUN was not obtained.
The Pearson correlation (Rp) was used to assess linear association, the median difference (Med) to evaluate bias, and the concordance correlation coefficient (Rc),
median absolute difference (Med||), and median %absolute difference (Med|%|) to evaluate overall agreement.
Table 4. Within-patient, longitudinal variability of selected parameters
Parameter Actual mean (SD) Number Median coefficient of variation % Mean|| (SD) Median||
Prescribed treatment time minutes 226.6 (25.6) 22 6.0 12.4 (16.6) 6.3
Delivered treatment time minutes 228.5 (25.5) 22 6.6 17.6 (14.7) 16.3
Prescribed Qb mL/min 368.2 (25.4) 22 2.4 11.2 (15.6) 4.2
Qb reported at 30 minutes mL/min 364.1 (19.4) 22 5.9 16.5 (16.0) 13.3
Prescribed Qd mL/min 545.3 (78.1) 22 0.0 47.6 (81.0) 0.0
Prescribed KT L 48.0 (7.3) 22 11.2 5.9 (3.4) 5.9
Urea G mg/min 11.1 (6.6) 22 30.1 3.1 (1.7) 2.5
eKt/Vrate 0.90 (0.19) 22 14.7 0.16 (0.08) 0.16
eKt/Vref 0.90 (0.19) 22 16.4 0.18 (0.09) 0.19
Predialysis weight kg 84.6 (17.0) 22 3.7 2.7 (2.4) 2.2
Postdialysis weight kg 82.0 (16.7) 22 2.9 2.5 (2.2) 2.2
Watson V L 41.0 (7.7) 22 1.8 0.8 (0.6) 0.6
Adjusted Chertow V L 43.7 (9.4) 22 2.7 1.2 (0.6) 1.2
Vdprate L 51.1 (11.0) 22 12.2 7.3 (4.0) 6.5
Vdpref L 51.0 (10.8) 22 13.4 8.1 (3.9) 7.4
Vdprate/body weight % 63.0 (10.7) 22 11.5 9.5 (6.9) 8.0
%AR 12.1 (9.1) 15 94.3 11.5 (8.7) 8.5
Mean and Median || denote mean and median of the absolute deviations between consecutive pairs of measurements.
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Fig. 3. Comparison of equilibrated Kt/Vrate versus equilibrated
Kt/Vref.
studied for at least two sessions (mean number of sessions
studied/patient = 4.6 over an average of 8.6 days). Vari-
ability in %AR was assessed in 15 patients (56 sessions).
Effect of intrasession variability in blood or dialysate
flow and of access recirculation
The full sample of 108 dialysis sessions included three
sessions with a variation in Qb > 100 mL/min, nine more
with Qd interruptions, a further 14 with therapy interrup-
tions, and seven more due to line reversal after starting
hemodialysis.
The mean ± SD reported actual Kt was similar in the
33 sessions with the noted technical difficulties (47.7 ±
5.8 L) and the remaining 75 sessions (47.6 ± 7.0 L, P =
0.54). However, there was a slightly greater shortfall (P <
0.001) in the mean reported actual Kt vs. the prescribed
Kt (2.1 L, or about 4%) in the sessions with technical
difficulties than in the remaining sessions (0.1 L). The
UKM estimates of V significantly exceeded the Watson
and Adjusted Chertow Vs in both sets of sessions (P <
0.001), but the difference between the UKM estimates
and Watson V tended to be slightly larger in the 33 ses-
sions with technical problems. The median% difference
between Vdprate and VWatson was 34.8% in sessions with
technical problems vs. 17.0% in the remaining sessions
(P = 0.09).
Mean AR was greater than 0 for 46 of the 63 sessions in
which AR was measured. AR was positively skewed; the
median and mean values for the 63 sessions were 7.0%
and 11.6% respectively, with a maximum AR of 47.5%.
For these 63 sessions, the mean Vdprate computed without
adjustment for AR was 52.4 ± 15.0 L. This was reduced
to 48.0 ± 13.6 L after adjustment of the dialyzer clearance
for AR. The median % difference between Vdprate and
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VWatson was 20.3% without adjustment for AR, and 12.3%
after AR adjustment. Similar results were obtained for
Vsp.
Effect of saline flushes
Among the 63 sessions in which AR was measured, 22
had none to one saline flush, 13 had two to six flushes,
and 28 had seven or more flushes. In a regression analysis
relating the % difference between Vdprate (with AR ad-
justment) and VWatson to the number of saline flushes, the
intercept corresponding to no flushes was 1.3% ± 4.0%
(P = 0.74) and the slope indicated a 2.9% ± 0.7% (P
< 0.001) increase in the% difference for each additional
flush above zero. The median % difference was 1.1%,
6.3%, and 19.0%, respectively, for sessions with none to
one, two to six, or ≥seven flushes, respectively. Thus, there
was no significant difference between Vdprate and VWatson
after adjusting for AR for sessions with no more than one
saline flush.
Development of prescription algorithm for eKt/V
The accuracy of prescribed eKt/V in estimating
achieved eKt/V was evaluated for the 79 dialysis ses-
sions for which there was at least one prior mod-
eling session for determination of prescribed eKt/V.
For these 79 sessions, mean (SD) actual eKt/Vref was
0.95 (0.27). The mean levels of prescribed eKt/V
based on the respective prescription algorithms were:
rx eKt/V(Watson), 1.08 (0.20); rx eKt/V(Adjusted Chertow), 1.03
(0.21); rx eKt/V(lastVdp), 0.91 (0.22); rx eKt/V(medVdp), 0.88
(0.19); rx eKt/V(wt.adj-medVdp), 0.94 (0.24). Comparisons
of the estimates of rx eKt/V with the actual delivered
eKt/Vref are shown in Figure 4. Consistent with the dif-
ferences between the anthropometric estimates of V and
Vdprate reported in Tables 1 and 2, the mean levels of
prescribed eKt/V under methods (1) and (2) were signifi-
cantly (P < 0.05) higher than for achieved eKt/Vref [mean
(SE) differences were 0.131 (0.025) and 0.082 (0.025) for
methods (1) and (2), respectively]. The median absolute
errors of delivered versus prescribed eKt/V were also
smaller for methods (3) to (5) (ranging from 0.126 to
0.132 Kt/V units) than for method (1) based on the Wat-
son V (with median absolute error = 0.167 Kt/V units).
However, reflecting the greater stability of the Adjusted
Chertow V over time than the model-based estimates of
V (see Table 4), the median absolute error of 0.127 be-
tween prescribed and achieved eKt/V for method (2) was
similar to the median absolute errors for methods (3) to
(5).
DISCUSSION
The optimal method of measuring delivered dialysis
dose in ARF remains unclear. The heterogeneous nature
of both the intensive care unit ARF population and the in-
dividual subject’s clinical course complicates generic ap-
proaches to dosing. Steady-state assumptions, with regard
to urea generation rate and urea distribution volume, al-
low delivered dose to be assessed through relatively in-
frequent application of formal UKM in ESRD [9, 10], but
dialysis prescription and assessment of its delivery may
need much more frequent assessment to adequately de-
scribe dose in the dynamic setting of intensive care unit
ARF.
Although discussed by Garred et al [28], only a limited
number of studies have actually examined IHD dosing
in ARF [19–22]. Underprescription of dialysis and pre-
scription delivery shortfalls have been described [19] but
interpretation of results is hampered by the use of various
simplified kinetic formulas that have yet to be validated
in ARF.
Urea kinetic relationships have been more rigorously
studied in the setting of sustained low-efficiency dialysis
(SLED) [29], although the applicability of findings in this
hybrid modality to IHD is not clear.
Our study is the first to apply formal double-pool
blood-side UKM in a prospective study of intensive care
unit ARF patients. We used this information to obtain
information about urea distribution volume, urea gener-
ation rate, and the extent of postdialysis urea rebound.
By examining serial sessions from dialysis initiation, it
was also the first study to allow dialysis prescription and
its delivery to be tracked along with changing clinical
conditions. We first validated the venous form of the
Daugirdas-Schneditz rate equation against an estimate of
eKt/V computed by formal dpvv UKM, and then aimed
to employ the rate equation to define practical methods
of prescribing a target eKt/V and describe potential im-
pediments to its achievement.
Hypercatabolism (reflecting that found in other, criti-
cally ill, ARF populations [11, 12, 14, 21]) and a picture
of considerable intersession variability in a wide variety
of clinical and dialytic parameters, emphasized the dis-
tinct nature of our subject group and the need to adopt a
different approach to that used in ESRD populations.
Using the Kt/V approach to quantify dialysis, we found
that the single-session, delivered dialysis dose tended to
be low in these intensive care unit ARF patients com-
pared to United States norms for chronic hemodialysis
patients being dialyzed three times per week [8]. The
mean spKt/V was 1.00 ± 0.23, but fell below 0.80 in 6 of
the 28 patients—serious underdialysis if this had occurred
in a chronic ESRD population being dialyzed three times
per week. The delivery of low Kt/V, despite relatively long
treatment times and high blood flows, is explained in part
by the tendency of the kinetic V to systematically exceed
anthropometric estimates of V. This discrepancy deserves
more detailed discussion.
The Watson formulas were derived from labeled
water and antipyrine dilution studies in nonuremic, adult
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Fig. 4. Comparison of (A) rx eKt/V(Watson), (B) rx eKt/
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subjects [24] but is routinely used in the assessment
of hemodialysis adequacy in ESRD [8]. However, in
stable, chronic hemodialysis patients, the Watson anthro-
pometric formulas have been shown to significantly over-
estimate urea distribution volume in comparison to both
13C-urea isotopic dilution techniques and direct dialysate
quantification-based UKM (by around 26%) [30], pos-
sibly relating to dialysis-related hemodynamic changes,
differing body composition, or differing degrees of hy-
dration of fat-free mass in chronic hemodialysis patients.
These findings have been corroborated by recent reports
that show the ratio of modeled V to Watson V to be
considerably lower than 1.0, in ESRD patients (personal
communication, John Daugirdas, on behalf of the HEMO
study).
In the present study, the finding of Watson anthropo-
metric Vs, significantly lower than modeled Vs, was only
partially rectified by use of an adjustment of the Chertow
V (a chronic hemodialysis population-specific regression
equation, validated against bioelectrical impedance, it-
self validated, previously, using deuterium oxide dilution
techniques) [25]. The results of analyses of the subset of
sessions with AR measurements suggested that the ten-
dency of the UKM estimates of V to exceed the anthro-
pometric estimates was due, primarily, to a combination
of AR and the dilutional effects of saline flushes. Saline
flushes would act to dilute the blood compartment urea
level below that predicted from standard double-pool
modeling. This would result in a lower than expected in-
tradialytic BUN profile during dialysis, a reduced amount
of urea removed, and an apparent increase in urea distri-
bution volume.
It must be remembered that the urea volume of distri-
bution derived from blood-sided UKM is an apparent vol-
ume. Modeled V is essentially calculated as the amount
of urea removed divided by the change in BUN concen-
tration (predialysis – equilibrated postdialysis) around a
dialysis session. As a result, apparent or modeled V will be
increased whenever the amount of urea removed during
a given session is overestimated. Blood-side urea model-
ing estimates the amount of urea removed as the product
of dialyzer clearance multiplied by the time-averaged in-
tradialytic urea level, multiplied by the session length. A
variety of technical problems can result in overestima-
tion of each of these three terms. We measured in vivo
dialyzer clearance and blood flow rate was confirmed by
ultrasound dilution, so the dialyzer clearance term was
probably correct, although we did find that the ratio of
modeled to anthropometric volumes may have been in-
creased in sessions with interruptions in either blood or
dialysate flow rate.
It is possible that discrepancies between anthropomet-
ric estimates of V and modeled V may have been com-
pounded by the marked fluid overload, existent in these
largely postsurgical patients. Such patients typically re-
ceive large amounts of fluid intraoperatively, often have
postoperative ileus with abdominal sequestration of fluid,
and also tend to receive fluid in the postoperative phase
in an attempt to maintain blood pressure and urine out-
put. Even in nonsurgical patients, fluid challenges prior
to dialysis are not uncommon, in an attempt to main-
tain urinary output prior to initiation of dialysis. Finally,
these patients commonly receive 2 to 4 L per day of in-
travenous fluids with medications and hyperalimentation,
and, when dialyzed on a three times per week schedule,
it becomes very difficult to correct initial hypervolemia,
or even to prevent progressive fluid gain. There is also
sequential loss of lean body mass in many of these pa-
tients, however, making it extremely difficult to quantify
the amount of overhydration. When a patient has gained
excess fluid, the water/weight ratio of this gain is close to
1.0, which then would result in an increase in the patient
water/weight ratio and a higher total body water than that
predicted from anthropometric equations. In support of
this overhydration mechanism, the ratio of modeled to
anthropometric volume was highest at the point of ini-
tiating dialysis, and this diminished over time as regular
dialysis treatments were applied.
In a previous paper, Himmelfarb et al [31] also found
that modeled urea volume exceeded Watson anthro-
pometric volumes by a substantial amount, although
the modeled urea volume estimates were not obtained
using formal urea kinetic methodology. It was specu-
lated that these differences may have been due to an
exaggerated urea disequilibrium in ARF patients due
to increased compartmentalization or intracellular urea
sequestration.
We had anticipated that, perhaps, there might be very
significant amounts of urea sequestration and postdialysis
urea rebound in these intensive care unit ARF patients,
many of whom have severely compromised circulation
to the extremities (where most urea is sequestered in the
muscle compartment) and many of whom are on pres-
sor drugs. Postdialysis rebound was, in fact, lower than
the 17% that is typically observed in chronic hemodialy-
sis [32] due to the low K/V and use of venovenous access
(thereby avoiding the rebound that would result from the
resolution of cardiopulmonary recirculation if arterio-
venous accesses had been used). The importance of ac-
counting for urea generation in the rebound, calculated
directly from the actual postdialysis BUNs (rather than
the curve-fit value, which had an intrinsic correction for
G), was at odds with previous work that suggested that
G impacted minimally on the perceived magnitude of re-
bound [20].
Others have found the inter-compartmental mass
transfer coefficient of urea, Kc, to vary widely, both be-
tween individuals (from 363 to 1249 mL/min) and within
the same individual [mean CV 30% (12% to 91%) on
maintenance hemodialysis for ESRD [33]. This compared
with a median Kc of 940 mL/min in our studied
sessions.
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From a practical viewpoint, it was evident that a sin-
gle, delayed posthemodialysis BUN was sufficient for
the formal double-pool kinetic modeling, and that the
Daugirdas-Schneditz venous rate equation provided a
suitable and pragmatic alternative to this in clinical set-
tings where a delayed sample could not be practically
obtained.
The analysis of serial sessions within the same patient
gave the present study the unique advantage of being
able to assess the impact of within-patient, longitudinal
variation in various clinical and dialytic factors. Individ-
ual components of the dialysis prescription varied with
a median CV of <7%, although the cumulative effect
was of more considerable variation in the overall dialysis
prescription. The variation in the measurements of dose
delivered to a given subject was somewhat higher, with a
median CV of over 16% for eKt/Vref. The higher variation
in delivered dose is to be expected, since variations in de-
livery as well as laboratory error and other forms of mea-
surement error affect the calculation of delivered dose, in
addition to the prescription. The relatively large variation
in the urea generation rate, G, is consistent with reports of
varying degrees of catabolism in such patients over time
[11–13]. The variability of Vdprate/body weight may have
reflected a complex interplay between fluid compartment
disturbances and changes in lean body mass in these crit-
ically ill subjects. The wide range of measured residual
renal function, evident in Table 1, illustrates the impor-
tance of accounting for this factor in kinetic calculations.
In a chronic dialysis setting, modeled urea distri-
bution volume (V) derived from some average of
previous sessions can be used to prescribe dialysis for
subsequent sessions. If one knows the ratio of modeled V
to anthropometric V, anthropometric V can also be used
in prescribing dialysis, especially for the initial prescrip-
tion, although even in chronic ESRD patients, the ratio
of modeled to anthropometric V is substantial.
In the present study, among the different parameters
considered in Table 4, the variability in the estimates of V
are most relevant to the ability of prescription algorithms
to reliably predict the actual delivered eKt/V. The within-
patient, intersession variability in Vdprate was substantial
[median absolute deviation (Med||) was 6.5L or about
12% of the mean Vdprate] (see Table 4). This was consider-
ably greater than within-patient, intersession variability
in the anthropometric estimates of V. Thus, although the
prescription algorithm based on the Adjusted Chertow V
overestimated delivered eKt/V by a median of 0.06 Kt/V
units (Fig. 4B), agreement between prescribed and deliv-
ered eKt/V was similar, when using the Adjusted Chertow
V and the algorithms based on Vdprate (see Fig. 4). Use
of the Vdprate from the last session, the median Vdprate
from all preceding sessions or the Adjusted Chertow V
provided the most accurate agreement with delivered
eKt/Vref among the methods considered here. Each of
these methods could be used to prescribe an eKt/V in
routine clinical practice on the understanding that vari-
ous impediments to dose delivery could cause a greater
shortfall and that any clinical trial examining dose deliv-
ery would require substantial differences in target eKt/V
to allow adequate separation of each dose arm. If the Ad-
justed Chertow V is used, it may be advisable to apply an
upward adjustment of 10% to 20% to the estimated V
prior to determining the dialysis prescription in order to
avoid an average shortfall in delivered eKt/V.
In summary, we have demonstrated the utility of
double-pool UKM in an intensive care unit ARF popula-
tion, with estimation of urea generation based on serum
urea changes in the pre- and postdialytic intervals. A va-
riety of potential impediments to the achievement of a
target eKt/V have been described, yet we still found rea-
sonable accuracy of prescription algorithms that used ki-
netic estimates of Vdp and an Adjusted Chertow V.
CONCLUSION
A double-pool kinetic approach to IHD dosing in in-
tensive care unit ARF patients is feasible but will re-
quire much more frequent application than in ESRD. The
present study highlights the differences between ESRD
and intensive care unit ARF patients, and in the applica-
tion of IHD dosing to these very different populations.
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APPENDIX
BASIC UREA KINETIC MODELING (KM)
FORMULAS
Part 1. Calculation of G
For the first iteration of the algorithm defined in the Methods section,
define
ltime = time interval between preceding KM session end and current
KM session start
ntime = time interval between current KM session end and next KM
session start
Wtpre = predialysis weight of current KM session
Wtpos = post-dialysis weight of current KM session
lWtpos = post-dialysis weight of preceding KM session
nWtpre = pre-dialysis weight of following KM session
b1 = (Wtpre – lWtpos)/ltime
b2 = (nWtpre – Wtpos)/ntime
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ldtime = time interval between preceding interdialytic sample
and session start
ndtime = time interval between session end and following
interdialytic sample
Wta1 = Wtpre – b1 × ldtime
Wta2 = Wtpos + b2 × ndtime
Wt60 = Wtpos + b2 × 60
V = Watson V (from postdialysis weight)
Vpre = V + Wtpre − Wtpos
V1 = V + Wta1 – Wtpos
V2 = V + Wta2 – Wtpos
V60 = V + Wt60 - Wtpos
Krb1 = (Kr + b1)/b1
Krb2 = (Kr + b2)/b2
Vratio1 = V1/Vpre
Vratio2 = V60/V2
Gpre = (Kr + b1) × (Cpre – C1 × vratio1Krb1)/(1 – vra-
tio1Krb1)
Gpos = (Kr + b2) × (C2 – C60 × vratio2Krb2)/(1 – vra-
tio2Krb2)
G = (Gpre + Gpos)/2
where Cpre = predialysis BUN, C60 = 60 minutes postdialysis BUN,
C1 = interdialytic BUN at least 4 hours prior to start of session, C2
= interdialytic BUN at least 4 hours after session, Gpre = predialysis
G, Gpos = postdialysis G, and G = estimated G during dialysis. In
subsequent iterations, the above set of equations is again applied using
Vdprate in place of the Watson V.
Part 2.
Vdp(wtadj) = Vdprate(median)
+ [postWt(session) − postWt(median)]
where postWt(session) denotes the postdialysis weight for the individ-
ual dialysis session, and postWt(median) denotes the median postdial-
ysis weight for the patient.
Part 3a. Watson formula
Male: Total body water = 2.447 − (0.09516 × age)
+ (0.1074 × height)
+ (0.3362 × weight)
Female: Total body water = −2.097 + (0.1069 × height)
+ (0.2466 × weight)
where weight denotes the postdialysis weight.
Part 3b. Chertow formula
Predialysis V
= −(0.07493713 × age)
− (1.01767992 × male) + (0.12703384 × height)
− (0.04012056 × weight) + (0.57894981 × diabetes)
− (0.00067247 × weight2) − 0.03486146
× (age × male) + 0.11262857 × (male × weight)
+ 0.00104135 × (age × weight)
+ 0.00186104 × (height × weight)
where weight denotes the predialysis weight. We obtained an Adjusted
Chertow estimate of the postdialysis V by subtracting the net weight
loss from the Chertow predialysis V estimate.
Part 4. Formula for cross-dialyzer extraction ratio [9], and
computation of in vivo KoA
Extraction ratio = (Cin − Cout)/Cin
where Cin= inlet BUN, and Cout=outlet BUN at the time t of the cross-
dialyzer assessment. Given the extraction ratio, Qb, and the dialysate
flow Qd, the in vivo KoA was obtained using Michael’s equation [34].
Part 5. Calculation of Vdprate
C0 and Ct denote the pre- and postdialysis BUN, respectively, Ceqrate
denotes the equilibrated post-BUN based on the rate equation, and Vsp
denotes the single-pool V.
Fdp = Ct/Ceqrate
Vratio = log(Fdp × (C0/Ct))/[Fdp × log(C0/Ct)]
Vdprate = Vsp/Vratio
Part 6. Differential equations of the double-pool variable
volume model
dCe(t)/dt = [G + Kc × (Ci(t) − Ce(t)
− (Kd + Kr − Qf) × Ce(t)]/Ve(t)
dCi(t)/dt = −[Kc × (Ci(t) − Ce(t)]/Vi
dVe(t)/dt = −Qf
where Kd = dialyzer clearance, Kc = intercompartmental mass-transfer
coefficient of urea, Kr = residual renal clearance, Qf is the ultrafiltration
rate, Ci(t) = urea concentration in intracellular compartment, Ce(t) =
urea concentration in extracellular compartment, Ve(t) = volume of
extracellular compartment, and Vi is the volume of the intracellular
compartment.
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